- Home
- TRNR vs ATXI Comparison
TRNR vs ATXI Comparison
Compare TRNR & ATXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNR
- ATXI
- Stock Information
- Founded
- TRNR 2017
- ATXI 2015
- Country
- TRNR United States
- ATXI United States
- Employees
- TRNR N/A
- ATXI N/A
- Industry
- TRNR Consumer Electronics/Appliances
- ATXI Biotechnology: Pharmaceutical Preparations
- Sector
- TRNR Technology
- ATXI Health Care
- Exchange
- TRNR Nasdaq
- ATXI Nasdaq
- Market Cap
- TRNR 3.9M
- ATXI 3.7M
- IPO Year
- TRNR 2023
- ATXI 2017
- Fundamental
- Price
- TRNR $1.33
- ATXI $0.77
- Analyst Decision
- TRNR
- ATXI
- Analyst Count
- TRNR 0
- ATXI 0
- Target Price
- TRNR N/A
- ATXI N/A
- AVG Volume (30 Days)
- TRNR 36.5M
- ATXI 61.2K
- Earning Date
- TRNR 03-31-2025
- ATXI 03-25-2025
- Dividend Yield
- TRNR N/A
- ATXI N/A
- EPS Growth
- TRNR N/A
- ATXI N/A
- EPS
- TRNR N/A
- ATXI N/A
- Revenue
- TRNR $3,180,000.00
- ATXI N/A
- Revenue This Year
- TRNR $1,543.45
- ATXI N/A
- Revenue Next Year
- TRNR $54.84
- ATXI N/A
- P/E Ratio
- TRNR N/A
- ATXI N/A
- Revenue Growth
- TRNR 226.82
- ATXI N/A
- 52 Week Low
- TRNR $0.86
- ATXI $0.77
- 52 Week High
- TRNR $1,640.00
- ATXI $13.13
- Technical
- Relative Strength Index (RSI)
- TRNR 41.14
- ATXI 20.72
- Support Level
- TRNR $1.33
- ATXI $0.93
- Resistance Level
- TRNR $1.68
- ATXI $1.07
- Average True Range (ATR)
- TRNR 0.67
- ATXI 0.09
- MACD
- TRNR -0.00
- ATXI -0.02
- Stochastic Oscillator
- TRNR 15.30
- ATXI 0.00
About TRNR Interactive Strength Inc.
Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.
About ATXI Avenue Therapeutics Inc.
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.